<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03262155</url>
  </required_header>
  <id_info>
    <org_study_id>35RC16_3037_IMPECstudy</org_study_id>
    <nct_id>NCT03262155</nct_id>
  </id_info>
  <brief_title>Study of Immunity Dysfunction Induced by Extracorporeal Assistance (ECMO / ECLS)</brief_title>
  <acronym>IMPEC</acronym>
  <official_title>Study of Immunity Dysfunction Induced by Extracorporeal Assistance (ECMO / ECLS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study of immunosuppression biomarkers in patients with ARDS or cardiogenic shock with ECMO /
      ECLS, compared to patients with ARDS or cardiogenic shock without ECMO / ECLS
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 4, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2017</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of immunosuppression in patients with ARDS or cardiogenic shock under ECMO / ECLS hospitalized in intensive care unit</measure>
    <time_frame>Hour 24</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Acute Respiratory Distress Syndrome</condition>
  <condition>Cardiogenic Shock</condition>
  <arm_group>
    <arm_group_label>ECMO / ECLS</arm_group_label>
    <description>Patients hospitalized for ARDS or Cardiogenic shock with ECMO / ECLS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No ECMO / ECLS</arm_group_label>
    <description>Patients hospitalized for ARDS or Cardiogenic shock without ECMO / ECLS</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood test</intervention_name>
    <arm_group_label>ECMO / ECLS</arm_group_label>
    <arm_group_label>No ECMO / ECLS</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients hospitalized for ARDS or Cardiogenic shock with or without ECMO / ECLS
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient older than 18 years old

          -  Patient hospitalized in an intensive care unit

          -  Patient whose initial ARDS or Cardiogenic shock began less than 5 days before
             admission

          -  Patients hospitalized for ARDS or Cardiogenic shock with ECMO / ECLS or - Patients
             hospitalized for ARDS or Cardiogenic shock without ECMO / ECLS

        Exclusion Criteria:

          -  Opposition of patient, relative or legal representative for participation in the study

          -  Pregnant woman

          -  Pre-immunodepression

          -  Implementation of immunosuppressive therapy such as chemotherapy, cyclophosphamide,
             high-dose corticosteroids (&gt; 0.5mg / kg / day).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean-Marc Tadié, MD, PhD</last_name>
    <phone>02.99.28.42.48</phone>
    <email>jeanmarc.tadie@chu-rennes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Marc Tadié, MD, PhD</last_name>
      <phone>02.99.28.42.48</phone>
      <email>jeanmarc.tadie@chu-rennes.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 23, 2017</study_first_submitted>
  <study_first_submitted_qc>August 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2017</study_first_posted>
  <last_update_submitted>August 23, 2017</last_update_submitted>
  <last_update_submitted_qc>August 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Shock, Cardiogenic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

